跳至主要内容
临床试验/JPRN-UMIN000025072
JPRN-UMIN000025072招募中未知

Japanese registry of Rivaroxaban effectiveness & safety for the prevention of recurrence in patients with Deep Vein Thrombosis and Pulmonary Embolism

ihon University School of Medicine0 个研究点目标入组 1,000 人开始时间: 2016年11月30日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Patients with symptomatic or asymptomatic venous thromboembolism prescribed rivaroxaban for the purpose of treatment and prevention of recurrence of acute deep vein thrombosis and pulmonary embolism

排除标准

  • 1. Patients with a contraindication to rivaroxaban
  • 2. Patients with chronic thromboembolic pulmonary hypertension (however, it is possible to register if there is coexisting acute pulmonary embolism or deep vein thrombosis)
  • 3. Patients with active bleeding
  • 4. In addition, patients determined to be inappropriate for the study by the attending doctor

研究者

发起方
ihon University School of Medicine

相似试验